Market Cap
1892689920.00
IOVA
Iovance Biotherapeutics, Inc.
Exchange: nyse
Multiples
- P/E: -4.62
- P/BV: 2.45
- P/TBV: 3.24
Description:
IOVA is the ticker symbol for Iovance Biotherapeutics, Inc., a biotechnology company listed on the New York Stock Exchange (NYSE). The company focuses on developing novel T-cell therapies for the treatment of cancer. Iovance's approach involves using a patient's own immune cells, which are genetically modified to target and destroy cancer cells more effectively. This innovative method holds promise in the field of immunotherapy, potentially offering new hope to patients suffering from various forms of cancer.
Data:
Yields:
Earnings Yield
1.281822494444
Return on Capital
-4.494067489929
CAGR (net income)
0%
CAGR Length
0
Dividend Rate
